Compatible Effect of Remimazolam Besylate Combined With Afentanil for ATI
Clinical trial NCT06026566 · UNKNOWN
Trial details
- NCT number
- NCT06026566
- Sponsor
- Tongji Hospital
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2023-04-01
- Primary completion
- 2025-08-31
- Enrollment
- 180
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.